Cite
APA Citation
Kraaij, T., Kamerling, S., Rooij, E. d., Daele, P. v., Bajema, I., Bredewold, O., Huizinga, T., Rabelink, T., Kooten, C. v., & Teng, Y. (n.d.). sAT0258 Synergetic b-cell immunomodulation with rituximab and belimumab is clinically effective in severe and refractory systemic lupus erythematosus – the synbiose proof-of-concept study. Annals of the rheumatic diseases, 76, 871. http://access.bl.uk/ark:/81055/vdc_100135161437.0x000062